Stay tuned, there is more to come in:
Need more information? Click here to connect with Kurin.
- Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination
- ENA Welcomes Kurin to 2023 Corporate Engagement Council
- Kurin Announces Kurin Jet, A Quantum Leap Forward in Devices Designed to Address Blood Culture Contamination
- Kurin, Inc. Announces Successful FDA Audit
- Kurin, Inc. Provides Update on Litigation Activity
- Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle
- U.S. District Court Enters Judgment of No Infringement of Patent Asserted Against Kurin Inc. by Magnolia Medical Technologies, Inc.
- Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System
- Kurin, Inc. Announces Agreement with AllSpire Health GPO to Impact Contaminated Blood Cultures
- Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™